NASDAQ, ANIK - Anika Therapeutics
Anika Therapeutics, Inc. ("Anika," the "Company," "we," "us," or "our") was
incorporated in 1992 as a Massachusetts company. Anika develops, manufactures
and commercializes therapeutic products for tissue protection, healing and
repair. These products are based on hyaluronic acid (HA), a naturally occurring,
biocompatible polymer found throughout the body. Due to its unique biophysical
and biochemical properties, HA plays an important role in a number of
physiological functions such as the protection and lubrication of soft tissues
and joints, the maintenance of the structural integrity of tissues, and the
transport of molecules to and within cells. Our currently manufactured and
marketed products consist of ORTHOVISC?, which is an HA product used in the
treatment of some forms of osteoarthritis in humans; AMVISC?, AMVISC? Plus,
STAARVISC?-II, and ShellGel?, each an injectable ophthalmic viscoelastic HA
product. ...
Read SEC Filing on NASDAQ.com »